Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
CMND stock price ended at $1.13 on 金曜日, after rising 3.67%
On the latest trading day Feb 13, 2026, the stock price of CMND rose by 3.67%, climbing from $1.09 to $1.13. Throughout the session, the stock experienced a volatility of 3.67%, with prices fluctuating between a daily low of $1.09 and a high of $1.13. Alongside this price increase, trading volume also rose by 22.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 19.2K shares were traded, amounting to a market value of approximately $67.7M.